Standard Versus Advanced Antimicrobial Dressing Containing Ionic Silver Following Colorectal Cancer Surgery (AM)

September 10, 2012 updated by: European Institute of Oncology

Surgical Sites Infections Following Colorectal Cancer Surgery. A Randomized Prospective Trial Comparing Standard and Advanced Antimicrobial Dressing Containing Ionic Silver.

The purpose of this study is to evaluate the efficacy of treatment with hydrofibre dressing in comparison with the efficacy of standard dressing in terms of prevalence of surgical site infections (SSI) in patients who underwent colorectal resection for malignancy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy
        • European Institute of Oncology
      • Monza, Italy, 20052
        • S. Gerardo Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients bearing solid tumours who are candidate to open radical surgery for colorectal cancer (histology proven)
  • Age 18-75
  • Informed signed consent
  • Performance Status 0-2 (according to ECOG score)
  • Platelets > 50.000/mm3
  • Prothrombin Time (Quick) > 60%
  • White Blood Cells > 2500/mm3
  • Life Expectancy > 3 months

Exclusion Criteria:

  • Intestinal obstruction
  • Severe intestinal bleeding requiring blood transfusion
  • Age under 18 or over 75
  • Severe hepatic failure (ascites, portal hypertension, jaundice or encephalopathy)
  • Renal failure (hemodialysis, creatinin > 2.5 mg/dL)
  • Active infections
  • Coagulopathy
  • Inability to give an informed consent
  • Known allergies to dressing components

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Mepore Self-adhesive absorbent dressing
Standard dressing: medication performed as for frequency and duration according standard procedure
Experimental: AQUAGEL Ag Hydrofiber Wound Dressing
Hydrofibre dressing containing ionic silver: medication performed as for frequency and duration according standard procedure
Other Names:
  • AQUAGEL Ag Hydrofiber Wound Dressing (ConvaTee,US)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The rate of patients with a Surgical site infection
Time Frame: 30 days after surgery
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2008

Primary Completion (Actual)

October 1, 2010

Study Completion (Actual)

December 1, 2010

Study Registration Dates

First Submitted

August 31, 2009

First Submitted That Met QC Criteria

September 21, 2009

First Posted (Estimate)

September 22, 2009

Study Record Updates

Last Update Posted (Estimate)

September 11, 2012

Last Update Submitted That Met QC Criteria

September 10, 2012

Last Verified

September 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe